Not available
Quote | Bio-Rad Laboratories Inc. Class A (NYSE:BIO)
Last: | $276.94 |
---|---|
Change Percent: | -0.49% |
Open: | $271.38 |
Close: | $276.94 |
High: | $277.63 |
Low: | $270.59 |
Volume: | 193,966 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
News | Bio-Rad Laboratories Inc. Class A (NYSE:BIO)
2024-07-04 05:50:00 ET Summary Ariel Investments, LLC is a global value-based asset management firm founded four decades ago in 1983. Ariel serves individual and institutional investors through five no-load mutual funds and eleven separate account strategies. Ariel Appreciation Fu...
2024-06-26 06:30:00 ET Summary Ariel Investments, LLC is a global value-based asset management firm founded four decades ago in 1983. Ariel serves individual and institutional investors through five no-load mutual funds and eleven separate account strategies. During the quarter, o...
Message Board Posts | Bio-Rad Laboratories Inc. Class A (NYSE:BIO)
Subject | By | Source | When |
---|---|---|---|
Long and strong lets hope im right | SAE | investorshub | 05/02/2023 5:06:29 PM |
$BIO When is this gonna take off? | buhg1b | investorshub | 05/01/2023 2:34:39 AM |
$BIO Price gaining | SAE | investorshub | 04/30/2023 5:11:47 PM |
$BIO Price trading last up | PirateGary | investorshub | 04/30/2023 1:08:44 AM |
$BIO MomentumIts now | locksflooring | investorshub | 04/25/2023 2:33:56 AM |
News, Short Squeeze, Breakout and More Instantly...
Bio-Rad Laboratories Inc. Class A Company Name:
BIO Stock Symbol:
NYSE Market:
Bio-Rad Laboratories Inc. Class A Website:
2024-06-20 03:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-10 04:04:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that Anette Engelhardt will join the company as its new Executive Vice President and President of the Clinical Diagnostics Group, effective June 10, 2024. ...